Posted in | News | Nanomaterials

Quantum Materials Secures Funding to Expand Production of Tetrapod Quantum Dots

Quantum Materials Corp. (QMC) (QTMM) announced today that it has closed on funding necessary to acquire and deploy automated equipment for significantly increased Tetrapod Quantum Dot (TQD) production.

According to Quantum Materials Chairman and CEO Stephen B. Squires, "It is gratifying to progress into scaled TQD production and we look forward to positioning Quantum Materials to meet the anticipated market quantity requests for our engineered spectrum Tetrapod Quantum Dots."

Quantum Materials' Tetrapod Quantum Dot

This enabling investment has been made by the Central Texas based partnerships Carson Diversified Investments LP and Carson Haysco Holdings LP.   Representing the two groups, W.C. Carson commented:

"We feel that Quantum Material's production methodology and design produces a material that is uniquely superior in form and function to other nanocrystals currently being utilized in industry and evaluated for application.

"It's too often that innovative technology gets stuck in the lab, so we are pleased to facilitate the equipment acquisition to eliminate a significant barrier to entry for QMC.  We look forward to continuing our support of the company as its Tetrapod Quantum Dots progress toward adoption and large-scale manufacturing."

Squires added:

"As part of our ongoing discussions with industry participants in a number of quantum dot fields, we have made projections that this secured production capacity can fulfill demand for several joint development collaborations, expanded sales for niche markets and new evaluation, as well supply for in-house R&D needs."

In addition to manufacturing TQD's engineered to specific lighting, display and medical applications for leading manufacturers worldwide, Quantum Materials is also researching and developing TQD-infused films for medical devices, solid state lighting applications, electronic displays and quantum dot solar cells.

About Quantum Materials Corporation

Quantum Materials Corporation develops and manufactures Tetrapod Quantum Dots for use in medical, display, solar energy and lighting applications through its patent pending volume production process. Quantum dot semiconductors enable a new level of engineered performance in a wide array of established consumer and industrial products. QMC's volume manufacturing methods enable consistent QD quality and scalable cost reductions to drive innovative discovery to commercial success.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    QM Cell Dots. (2019, February 11). Quantum Materials Secures Funding to Expand Production of Tetrapod Quantum Dots. AZoNano. Retrieved on October 13, 2024 from https://www.azonano.com/news.aspx?newsID=29344.

  • MLA

    QM Cell Dots. "Quantum Materials Secures Funding to Expand Production of Tetrapod Quantum Dots". AZoNano. 13 October 2024. <https://www.azonano.com/news.aspx?newsID=29344>.

  • Chicago

    QM Cell Dots. "Quantum Materials Secures Funding to Expand Production of Tetrapod Quantum Dots". AZoNano. https://www.azonano.com/news.aspx?newsID=29344. (accessed October 13, 2024).

  • Harvard

    QM Cell Dots. 2019. Quantum Materials Secures Funding to Expand Production of Tetrapod Quantum Dots. AZoNano, viewed 13 October 2024, https://www.azonano.com/news.aspx?newsID=29344.

Comments

  1. Gene Shoot Gene Shoot United States says:

    Commend CEO Squires and Carson for their long term efforts and pending success!  Long time coming!!

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoNano.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.